The research process

The Foundation’s team of researchers measures company behaviour using a rigorous process of data-collection, verification, scoring and analysis. Find out more about what these phases involve.

Data-collection and verification

During data-collection, the research team uses public sources of information as well as data submitted directly by the companies evaluated. These sources include the US FDA, the European Medicines Agency, Health Canada, ClinicalTrials.gov, MedsPal, LexisNexis, annual filings and reports from companies, amongst others. 

During this phase, the research team follows a detailed process for verifying and clarifying the data it analyses. This includes requesting specific supporting documentation from companies as proof that the strategies and policies they report are being implemented in practice, including the codes of conduct, internal policies, and processes for engaging with stakeholders. The team also uses public registries of information, such as the US FDA's Orange Book, to cross-check certain data sets. Information about partnerships is also verified using information in the public domain, often published by product development partnerships (DNDi, MMV, etc).

Scoring the companies

The research team scores the companies in each of the Benchmark metrics against a strict set of scoring guidelines, developed with reference to external experts. The research team compiles an extensive, detailed database of all products and R&D projects that qualify for analysis by the Index, as a central analytical platform. In 2018, the database includes 741 products and 276 R&D projects.

Progress and gap analysis

Once scoring is complete, the team begins combing the data to assess the current level of activity across the industry on AMR, as well as signs of progress or stagnation. The analysis shows how a cross-section of the industry is responding to AMR by benchmarking them against the consensus view on where they can and should be making progress. Once analysis is complete, key sections of the report are shared with independent experts for their view on the findings.


Learn more

View our detailed overview of each company’s performance